Sanofi S.A. is a French multinational pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical drugs, vaccines, and consumer healthcare products.
This financial overview details the FR0012146801 bond, a debt security issued by Sanofi S.A., a leading global pharmaceutical and healthcare company headquartered in France. Denominated in EUR, this bond featured an annual interest rate of 1.75% and made payments on an annual frequency. The instrument reached its maturity on September 10, 2026, and was subsequently redeemed at 100% of its principal value, concluding its lifecycle and ensuring full repayment to bondholders.
|